PMC3861871_01
Marked improvement of psoriasis during treatment with adalimumab. a Before treatment. b After 3 months. c After 8 months.
cde-0005-0332-g01.jpg
PMC3861871_01_cde-0005-0332-g01.jpg
F1
After 3 months of therapy with adalimumab, a marked improvement of his psoriasis (PASI 75 response) was observed (fig. 1a, b). Together with further amelioration of the psoriatic lesions (fig. 1c), a marked improvement of his AD was subsequently also observed during the following 5 months (fig. 2e-h).
a-d Flare-up of AD at month 3. e-h Subsequent amelioration of AD after application of topical corticosteroids for 6 weeks and continuing treatment with adalimumab with a few remaining lesions after 8 months.
cde-0005-0332-g02.jpg
PMC3861871_01_cde-0005-0332-g02.jpg
F2
However, together with this improvement, new eczematous lesions had begun to flare up on his neck, armpits, and hands (fig. 2a-d).